Oscar Health, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
Oscar Health, Inc. reported a significantly wider net loss in the third quarter of 2025 despite substantial revenue and membership growth, driven by increased medical expenses and risk adjustment transfers.
NYSE
Oscar Health, Inc. reported a significant net loss in Q2 2025 despite strong revenue and membership growth, driven by increased medical expenses and risk adjustment transfers.
NYSE
Oscar Health's Q1 2025 results show significant revenue growth and profitability, driven by a substantial increase in membership.
NYSE
Oscar Health's Q3 2024 results show significant membership growth and improved financial metrics, despite a net loss for the quarter.
NYSE
Oscar Health's Q2 2024 results show significant revenue growth and improved profitability, driven by a substantial increase in membership and better management of medical costs.
NYSE
Oscar Health's first quarter of 2024 saw a significant increase in revenue and a return to profitability, driven by membership growth and improved cost management.